Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Rheumatology
•
Rheumatoid Arthritis
•
Cancer
What is your approach to treating active rheumatoid arthritis in patients with metastatic breast cancer on palbociclib and faslodex?
Related Questions
What is your approach to the diagnosis of LGL leukemia or Felty's Syndrome in a patient with rheumatoid arthritis?
How would you approach rheumatoid arthritis treatment for widespread large rheumatoid nodules but no active synovitis or subjective joint pain?
Do you consider Anti-carbamylated protein antibodies (anti-CarP) as having any significance in evaluation of patients if RF and ACPA negative and clinically no active synovitis yet widespread arthralgias and generalized osteoarthritis?
Are there concerns with combining anti-IL5 biologics (mepolizumab or benralizumab) for severe asthma with other biologics for RA (e.g. TNFi)?
How you do approach management of a patient with previously well-controlled RA, who is now having recurrent flares of multiple joints which is resistant to even high dose steroids?
How you do approach treatment for a patient with active seropositive RA (+RF/+CCP) who is receiving treatment for Hepatitis C?
What are best practices in management of severe acute infusion reaction from infliximab?
Would you consider adding dupilumab to adalimumab (or other monoclonal antibodies) in a patient who has RA and refractory atopic dermatitis and already is on MTX 25 mg weekly?
How do you approach the timing of DMARD initiation in patients with active RA who are on treatment for latent TB?
How do you approach an obese patient on long-term methotrexate with normal liver tests in terms of workup for underlying fatty liver?
